Please assess the completion status of the following clinical trial:

Trial Title: An Open Label Study of Severe Sepsis in Adults

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients greater than or equal 18 years of age may be included in this study only if they meet all of the following criteria:~  1. Must be 18 years.~ 2. Suspected or proven infection~ 3. Have or have had two or more sepsis-induced organ failures sepsis~Exclusion Criteria:~* Patients will be excluded from entry in this study for any of the following reasons:~  1. Documented first organ dysfunction greater than 48-hours prior to start of study drug.~ 2. Patients greater than 135 kg in weight.~ 3. Patients with a platelet count less than 30,000/mm3~ 4. Active internal bleeding or at increased risk for bleeding

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): 24 microgram/kg/hr for 96 hours (+ or - 1 hour)

Based on this trial design, predict the completion outcome and termination type (if applicable).